Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 531 | 531 | 531 |
Full Text Views | 4 | 4 | 4 |
PDF Downloads | 3 | 3 | 3 |
Fascioliasis, a food-borne trematodiasis, is a disease primarily identified in livestock, such as sheep and cattle. Human fascioliasis has been reported sporadically in Korea, but a recent increase in patients has been associated with a green vegetable juice delivery service. We aimed to investigate the serological and radiological findings of the patients treated for fascioliasis. Patients with peripheral eosinophilia, which is a positive antibody for Fasciola hepatica (F. hepatica) and liver abscess, were considered to have fascioliasis and were treated with triclabendazole at a dose of 10 mg/kg, administered twice. A total of 21 patients diagnosed with fascioliasis were included. Patients were categorized into the early and late diagnosis groups according to the time gap between the presentation and diagnosis. A comparison of initial magnetic resonance imaging (MRI) between the two groups revealed a filling defect of the bile duct that was more commonly observed in the late diagnosis group (72.7% versus 0%; P = 0.003). Hepatic abscess lesions resolved slowly, with 14.3%, 50%, and 85.7% of patients showing complete resolution on computed tomography 6, 12, and 24 months after treatment, respectively. The mean levels of anti-F. hepatica antibodies decreased after a 6-month follow-up (mean levels, onset versus 6-month, 12-month, or 24-month follow-up; 4.36 versus 3.29, 3.17, or 2.31, respectively; all P <0.01). Eosinophil counts reduced significantly 1 month after treatment and remained normal thereafter in both groups. This study suggests that MRI could be useful for diagnosing fascioliasis in a subgroup of patients and that hepatic abscesses and positive antibody results could last for several months after treatment.
Financial support: This research was supported by the
Disclosures: This study was approved by the ethical committee of Asan Medical Center (2023-1830). The requirement for informed consent was waived given the retrospective nature of the study.
Current contact information: Min Jae Kim, E-mail: nahani99@gmail.com. Eun Jeong Won, Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, E-mail: ejwon@amc.seoul.kr. Kyung-Won Kim, Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, E-mail: kyungwon.kim@amc.seoul.kr, Eui-Jin Chang, Jiwon Jung, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Sung-Han Kim and Min Jae Kim, Department of Infectious diseases, Asan Medical Center ,University of Ulsan College of Medicine, Seoul, Korea, E-mails: radiohead0618@amc.seoul.kr, trueblue27@naver.com, drchong@amc.seoul.kr, soleemd@amc.seoul.kr, sangho@amc.seoul.kr, yskim@amc.seoul.kr, shkimmd@amc.seoul.kr, and nahani99@gmail.com.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 531 | 531 | 531 |
Full Text Views | 4 | 4 | 4 |
PDF Downloads | 3 | 3 | 3 |